CSIMarket
 
Enzymotec Ltd.  (ENZY)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 23
 Employees 124
 Revenues (TTM) (Millions $) 48
 Net Income (TTM) (Millions $) -3
 Cash Flow (TTM) (Millions $) -14
 Capital Exp. (TTM) (Millions $) 2

Business Description


Enzymotec Ltd. is an Israeli-based company that specializes in the development, production, and marketing of lipid-based nutritional ingredients and medical foods. They aim to provide solutions for various health conditions through the utilization of innovative technologies and scientific research.

The company offers a range of products that are derived from natural sources and are designed to improve human health and well-being. These products include nutritional ingredients, such as omega-3 fatty acids, phospholipids, and plant sterols, which are used in various industries, including supplements, clinical nutrition, infant nutrition, and functional foods.

Enzymotec's products are backed by extensive scientific research and the company prides itself on its expertise in lipid science and technology. They have collaborations with researchers and academic institutions to continually develop and improve their offerings. Additionally, Enzymotec has a strong commitment to quality and sustainability, ensuring that their products meet the highest standards while minimizing their environmental impact.

With a presence in over 35 countries worldwide, Enzymotec works closely with its customers to provide tailored solutions to address their specific needs. Overall, the company's mission is to harness the power of lipids to enhance human health and improve people's quality of life.




   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 11.47
Working Capital Ratio 22.35
Leverage Ratio (MRQ) 0.05
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.13 $
Revenues (TTM) 2.1 $
Cash Flow (TTM) -
Cash 2.65 $
Book Value 6.01 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 384,645
Net Income per Employee (TTM) -23,573
Receivable Turnover Ratio (TTM) 4.75
Inventory Turnover Ratio (TTM) 23.82
Asset Turnover Ratio (TTM) 0.33

Profitability Ratios Current
Gross Margin (MRQ) 62.87 %
Operating Margin (MRQ) -6.53 %
Net Margin (MRQ) -6.13 %
Net Cash Flow Margin (MRQ) -30.2 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.